| __timestamp | ImmunityBio, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1595000 | 22223073 |
| Thursday, January 1, 2015 | 11434000 | 6966842 |
| Friday, January 1, 2016 | 26546000 | 9000499 |
| Sunday, January 1, 2017 | 39778000 | 13741186 |
| Monday, January 1, 2018 | 53418000 | 19040000 |
| Tuesday, January 1, 2019 | 111997000 | 23559000 |
| Wednesday, January 1, 2020 | 139507000 | 31931000 |
| Friday, January 1, 2021 | 195958000 | 44981000 |
| Saturday, January 1, 2022 | 248149000 | 54234000 |
| Sunday, January 1, 2023 | 232366000 | 63806000 |
Infusing magic into the data realm
In the competitive world of biotechnology, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, ImmunityBio, Inc. and Viking Therapeutics, Inc. have demonstrated contrasting approaches to R&D spending. ImmunityBio has consistently increased its R&D budget, peaking in 2022 with a 15-fold increase from 2014. This aggressive investment strategy underscores their commitment to pioneering advancements in immunotherapy. Meanwhile, Viking Therapeutics has adopted a more measured approach, with a steady increase in R&D spending, culminating in a nearly threefold rise by 2023. This strategy reflects their focus on targeted therapeutic areas. As these companies continue to innovate, their R&D spending patterns offer valuable insights into their strategic priorities and potential future breakthroughs.
R&D Spending Showdown: Gilead Sciences, Inc. vs ImmunityBio, Inc.
Comparing Innovation Spending: United Therapeutics Corporation and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Neurocrine Biosciences, Inc. vs Viking Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. vs ImmunityBio, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Alkermes plc and ImmunityBio, Inc. Allocate Funds
Analyzing R&D Budgets: Opthea Limited vs ImmunityBio, Inc.
Analyzing R&D Budgets: Viking Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Protagonist Therapeutics, Inc.
Comparing Innovation Spending: Viking Therapeutics, Inc. and Celldex Therapeutics, Inc.
Analyzing R&D Budgets: ACADIA Pharmaceuticals Inc. vs ImmunityBio, Inc.
ImmunityBio, Inc. or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: ImmunityBio, Inc. vs Novavax, Inc.